Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Article Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Team
    • Feedback
    • Reprints
    • Impact Factor
    • Editorial Fellowship Application Process
  • ASN Kidney News
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Article Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Team
    • Feedback
    • Reprints
    • Impact Factor
    • Editorial Fellowship Application Process
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum
Clinical Nephrology
You have accessRestricted Access

Additive Effect of ACE Inhibition and Angiotensin II Receptor Blockade in Type I Diabetic Patients with Diabetic Nephropathy

Peter Jacobsen, Steen Andersen, Berit R. Jensen and Hans-Henrik Parving
JASN April 2003, 14 (4) 992-999; DOI: https://doi.org/10.1097/01.ASN.0000054495.96193.BF
Peter Jacobsen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steen Andersen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Berit R. Jensen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans-Henrik Parving
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

Article Information

vol. 14 no. 4 992-999
DOI 
https://doi.org/10.1097/01.ASN.0000054495.96193.BF
PubMed 
12660333

Published By 
American Society of Nephrology
Print ISSN 
1046-6673
Online ISSN 
1533-3450
History 
  • Received for publication October 14, 2002
  • Accepted for publication December 9, 2002
  • Published online April 1, 2003.

Copyright & Usage 
© 2003 American Society of Nephrology

Author Information

  1. Peter Jacobsen*,
  2. Steen Andersen*,
  3. Berit R. Jensen* and
  4. Hans-Henrik Parving*†
  1. *Steno Diabetes Center, Gentofte, Denmark and †Faculty of Health Science, University of Aarhus, Denmark.
  1. Correspondence to Dr. Peter Jacobsen, Steno Diabetes Center, Niels Steensens Vej 2, 2820 Gentofte, Denmark. Phone: 45-44-43-90-97; Fax: 45-44-43-81-60;

Statistics from Altmetric.com

Article usage

Article usage: March 2003 to February 2021

AbstractFullPdf
Mar 2003298254165
Apr 2003623881349
May 2003100337153
Jun 20035215765
Jul 20039811651
Aug 20033512149
Sep 20033114259
Oct 20034617855
Nov 20033713938
Dec 20033010739
Jan 20043111328
Feb 20041610641
Mar 20043110229
Apr 200423126113
May 2004139486
Jun 2004207674
Jul 20045010370
Aug 200440104102
Sep 20041810474
Oct 20042411775
Nov 20043114088
Dec 20042214079
Jan 20052013091
Feb 20052712584
Mar 20051884103
Apr 200540124124
May 2005218764
Jun 2005206565
Jul 2005208970
Aug 2005187968
Sep 2005169283
Oct 2005179464
Nov 20052410388
Dec 200575552
Jan 2006209073
Feb 20061610166
Mar 20062111272
Apr 2006245755
May 2006195331
Jun 2006246454
Jul 2006286351
Aug 2006305238
Sep 2006278864
Oct 2006399968
Nov 2006317753
Dec 2006246540
Jan 2007238344
Feb 2007368863
Mar 2007238058
Apr 2007265538
May 2007266457
Jun 2007273637
Jul 2007324329
Aug 2007224537
Sep 2007154545
Oct 2007274949
Nov 2007114143
Dec 2007212831
Jan 2008235644
Feb 2008384840
Mar 2008263432
Apr 2008294844
May 2008274547
Jun 2008205231
Jul 2008234630
Aug 2008433132
Sep 2008515248
Oct 2008405637
Nov 2008224039
Dec 2008192320
Jan 2009293436
Feb 2009253429
Mar 2009243928
Apr 2009152828
May 200973923
Jun 2009232612
Jul 2009141624
Aug 2009102524
Sep 2009152327
Oct 2009354332
Nov 2009254330
Dec 2009152110
Jan 2010222922
Feb 2010152423
Mar 2010252720
Apr 2010242619
May 2010142917
Jun 2010232825
Jul 2010132519
Aug 2010164029
Sep 2010253019
Oct 2010183631
Nov 2010191818
Dec 2010274121
Jan 2011221617
Feb 2011263124
Mar 2011314028
Apr 2011271415
May 2011283124
Jun 2011242127
Jul 2011351526
Aug 2011171823
Sep 2011242319
Oct 2011372319
Nov 2011462929
Dec 2011242421
Jan 2012292320
Feb 2012401519
Mar 2012292417
Apr 2012372331
May 2012112616
Jun 2012272718
Jul 2012303115
Aug 2012322718
Sep 2012322024
Oct 2012461822
Nov 2012382322
Dec 2012331011
Jan 2013713916
Feb 2013371817
Mar 2013492115
Apr 2013381718
May 2013392616
Jun 2013202319
Jul 2013221314
Aug 2013161419
Sep 2013261933
Oct 2013281917
Nov 2013221537
Dec 2013201183
Jan 201436945
Feb 2014331336
Mar 2014152536
Apr 2014261240
May 2014291714
Jun 2014231621
Jul 20142910270
Aug 20141316329
Sep 2014171345
Oct 2014372253
Nov 2014161936
Dec 2014242033
Jan 2015241234
Feb 2015111724
Mar 2015443430
Apr 201525710
May 201515149
Jun 2015181815
Jul 2015171819
Aug 2015201410
Sep 201530910
Oct 2015261514
Nov 2015241612
Dec 201528258
Jan 2016302415
Feb 20164197
Mar 201613615
Apr 2016281312
May 2016364415
Jun 2016242620
Jul 2016232218
Aug 201612820
Sep 201614177
Oct 2016152112
Nov 2016221012
Dec 20164194
Jan 201732167
Feb 20172194
Mar 2017291212
Apr 20171986
May 20179107
Jun 20172474
Jul 201720135
Aug 2017141913
Sep 201712134
Oct 2017112114
Nov 20171963
Dec 20176142
Jan 201810418
Feb 20185182
Mar 2018172010
Apr 201815174
May 201813369
Jun 201816256
Jul 2018133114
Aug 201817246
Sep 2018152615
Oct 20183147
Nov 201884814
Dec 20186199
Jan 201952616
Feb 201952218
Mar 20195511
Apr 201941923
May 2019164
Jun 201971814
Jul 20192228
Aug 201961310
Sep 20193612
Oct 201956518
Nov 201982020
Dec 20193148
Jan 20204146
Feb 202082411
Mar 202051616
Apr 20205198
May 202041010
Jun 2020274
Jul 20206148
Aug 202021814
Sep 202020117
Oct 202072913
Nov 202041811
Dec 20206158
Jan 2021103242
Feb 2021597

Cited By...

  • 156 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Journal of the American Society of Nephrology: 14 (4)
Journal of the American Society of Nephrology
Vol. 14, Issue 4
1 Apr 2003
  • Table of Contents
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in JASN.
Enter multiple addresses on separate lines or separate them with commas.
Additive Effect of ACE Inhibition and Angiotensin II Receptor Blockade in Type I Diabetic Patients with Diabetic Nephropathy
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Additive Effect of ACE Inhibition and Angiotensin II Receptor Blockade in Type I Diabetic Patients with Diabetic Nephropathy
Peter Jacobsen, Steen Andersen, Berit R. Jensen, Hans-Henrik Parving
JASN Apr 2003, 14 (4) 992-999; DOI: 10.1097/01.ASN.0000054495.96193.BF

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Additive Effect of ACE Inhibition and Angiotensin II Receptor Blockade in Type I Diabetic Patients with Diabetic Nephropathy
Peter Jacobsen, Steen Andersen, Berit R. Jensen, Hans-Henrik Parving
JASN Apr 2003, 14 (4) 992-999; DOI: 10.1097/01.ASN.0000054495.96193.BF
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • References
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

  • A Randomized, Controlled Trial of Steroids and Cyclophosphamide in Adults with Nephrotic Syndrome Caused by Idiopathic Membranous Nephropathy
  • Lower Progression Rate of End-Stage Renal Disease in Patients with Peripheral Arterial Disease Using Statins or Angiotensin-Converting Enzyme Inhibitors
  • IgACE: A Placebo-Controlled, Randomized Trial of Angiotensin-Converting Enzyme Inhibitors in Children and Young People with IgA Nephropathy and Moderate Proteinuria
Show more Clinical Nephrology

Cited By...

  • Physiology of the Renal Interstitium
  • Potassium Handling with Dual Renin-Angiotensin System Inhibition in Diabetic Nephropathy
  • Recurrence of Secondary Glomerular Disease after Renal Transplantation
  • Effects of Additive Therapy With Spironolactone on Proteinuria in Diabetic Patients Already on ACE Inhibitor or ARB Therapy: Results of a Randomized, Placebo-Controlled, Double-Blind, Crossover Trial
  • Microalbuminuria in Type 2 Diabetes and Hypertension: A marker, treatment target, or innocent bystander?
  • Are Two Better Than One? Angiotensin-Converting Enzyme Inhibitors Plus Angiotensin Receptor Blockers for Reducing Blood Pressure and Proteinuria in Kidney Disease
  • Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study: A Randomized Controlled Study of Benazepril and Losartan in Chronic Renal Insufficiency
  • Albuminuria Is a Target for Renoprotective Therapy Independent from Blood Pressure in Patients with Type 2 Diabetic Nephropathy: Post Hoc Analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) Trial
  • Dual Blockade of the Renin-Angiotensin System in the Progression of Renal Disease: The Need for More Clinical Trials
  • Progression of Renal Disease: Renoprotective Specificity of Renin-Angiotensin System Blockade
  • ACE Inhibitor or Angiotensin II Receptor Antagonist Attenuates Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats
  • Systematic Review of Combined Angiotensin-Converting Enzyme Inhibition and Angiotensin Receptor Blockade in Hypertension
  • Long-Term Dual Blockade With Candesartan and Lisinopril in Hypertensive Patients With Diabetes: The CALM II study
  • Recent advances in diabetic nephropathy
  • Google Scholar

Similar Articles

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire